


FIT Medical Weight Loss in Albuquerque, NM operates a physician-supervised weight management program that integrates GLP-1 receptor agonist peptides with structured nutrition protocols and accountability systems. The clinic's approach centers on weekly in-person consultations where patients receive medication adjustments, body composition analysis, and dietary guidance tailored to individual metabolic responses. This Albuquerque location serves patients throughout the greater metro area with both scheduled appointments and telehealth options for follow-up visits.
The clinic's peptide therapy program features semaglutide and tirzepatide as primary pharmaceutical interventions for appetite regulation and glycemic control. Semaglutide dosing follows a graduated titration schedule beginning at 0.25 mg weekly, with increases based on tolerance and weight loss velocity. Tirzepatide protocols start at 2.5 mg weekly and may advance to higher doses depending on clinical response and side effect profile. Both medications are administered via subcutaneous injection, with patients receiving hands-on training during initial visits. The medical team monitors for common adverse effects including nausea, constipation, and injection site reactions, adjusting protocols to maintain therapeutic benefit while minimizing discomfort. Peptide therapy is combined with vitamin B12 and B6 supplementation to address potential nutrient deficiencies and support energy levels during caloric restriction phases.
FIT Medical Weight Loss employs licensed medical providers who conduct initial health assessments including metabolic panels, thyroid function tests, and cardiovascular screening before initiating peptide protocols. The Albuquerque clinic's physicians evaluate contraindications such as personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disease. Each patient receives a customized caloric target based on resting metabolic rate calculations and activity level, with macronutrient ratios adjusted for satiety and muscle preservation. The medical team provides specific meal planning frameworks rather than restrictive diet lists, teaching patients to build balanced plates using portion control tools and food quality guidelines.
Patients attend weekly weigh-ins and progress consultations where providers review food logs, address barriers to adherence, and modify treatment plans based on objective data. The accountability structure includes access to patient portals for tracking metrics between visits, educational resources on behavioral modification techniques, and direct messaging with clinic staff for questions about medication administration or dietary challenges. The program emphasizes skill-building for long-term weight maintenance, including strategies for navigating social eating situations, managing stress-related food behaviors, and transitioning off peptide therapy while sustaining results. Patients typically remain in active treatment for 12 to 24 weeks depending on weight loss goals and individual response rates.
The Albuquerque clinic offers transparent pricing structures with package options that bundle medical visits, peptide medications, and nutritional supplements into monthly fees. Telehealth consultations provide flexibility for established patients who require medication refills or have scheduling constraints, though initial assessments and periodic in-person evaluations remain mandatory for safety monitoring. FIT Medical Weight Loss does not accept insurance for weight management services but provides itemized receipts that patients may submit for potential HSA/FSA reimbursement or out-of-network benefits. The clinic's location in Albuquerque allows access for residents across Bernalillo County and surrounding areas including Rio Rancho, Los Lunas, and the East Mountains, with ample parking and ADA-accessible facilities.
Topics Mentioned in Reviews
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


